Alpha Profiles · Company Profile

Gain Therapeutics, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/gain-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: GANX
Verification: Partially verified
Last reviewed: 2026-09-05T21:32:18.743475+00:00

Overview

Alpha's canonical identity and public leadership record for Gain Therapeutics, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

3 public records

Gene Mack

Chief Executive Officer

State: confirmed
Effective: From Mar 26, 2026
Confidence: 94%
Evidence: GANX 10-K executive officersMar 26, 2026

Gianluca Fuggetta

Senior Vice President Finance

State: confirmed
Effective: From Mar 26, 2026
Confidence: 94%
Evidence: GANX 10-K executive officersMar 26, 2026

Melanie Alder

Chief Executive Officer

State: confirmed
Effective: From Mar 26, 2026
Confidence: 94%
Evidence: GANX 10-K executive officersMar 26, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 5, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.